Cold Spray's Role in Reducing Pain During Capillary Glucose Testing

Launched by ABANT IZZET BAYSAL UNIVERSITY · Jan 17, 2025

Keywords

ClinConnect Summary

This clinical trial is looking to see if using a cold spray can help reduce pain during blood glucose tests, which are often needed for people with diabetes or other health conditions. The researchers want to find out if the cold spray makes a difference in pain relief compared to a regular spray that doesn't have any active ingredients, known as a placebo. Participants in the study will be adults aged 18 and older who need to have at least two of these blood tests.

To take part, individuals must not have any allergies to the spray's ingredients or certain health conditions that can affect pain or blood sugar measurements. If eligible, participants will receive both the cold spray and the placebo spray in a specific order during their tests. Their pain levels will be recorded using a simple scale where they can indicate how much pain they feel. This study is not currently recruiting participants, but it aims to provide valuable information about ways to make routine blood tests more comfortable for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged ≥18 years
• • Patients requiring at least two capillary blood glucose measurements for any reason
• • Patients who agree to participate in the study
• Exclusion Criteria:
• • Allergy to the components of the spray
• • Conditions that may affect capillary blood glucose measurement or pain perception, such as peripheral neuropathy or peripheral arterial disease
• • Blood glucose levels outside the measurable range of the capillary device (extremely low or high levels)
• • Cognitive disorders that prevent the evaluation of the Visual Analog Scale (VAS), such as dementia, Alzheimer's disease, or cerebrovascular diseases
• • Severe conditions in other parts of the body that may interfere with pain evaluation